Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study.
about
Prevention of Alzheimer's diseaseStatins for the prevention of dementiaThe Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationCholesterol, statins, and dementia: what the cardiologist should knowStatins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory studyIncreased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis.Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.Are patients with dementia treated as well as patients without dementia for hypertension, diabetes, and hyperlipidaemia?Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis.The risk of dementia in relation to statins and other lipid lowering agents.Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline?A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion.Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease.The impact of dementia on the use of general practitioners among the elderly in NorwayCardiac risk factors and potential treatments in Alzheimer's disease.Use of statins and risk of hospitalization with dementia: a Danish population-based case-control studyEffects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trialUse of statins and incidence of dementia and cognitive impairment without dementia in a cohort studyModifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.Effect of dementia on the use of drugs for secondary prevention of ischemic heart disease.Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention.Therapeutic interventions targeting Beta amyloid pathogenesis in an aging dog model.Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Lipid metabolism in Alzheimer's diseaseThe role of cholesterol metabolism in Alzheimer's disease.Statins and cognitive function: an updated review.On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies.Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis.Treatment of latent stage Alzheimer’s disease with statins?
P2860
Q22248031-B3C7093A-6E70-4C0E-96B0-981D0F41990FQ24241335-AC0DC08C-B428-44BD-9DEF-77ADB625764FQ26823454-CD52C311-681A-4BCF-A6A3-26390EA7B0F5Q28081974-8AF8C8A2-F836-43BF-B9B5-3A3D4092463AQ30417962-32C9459B-7588-4D5B-8898-B859950371EBQ30484210-2A9B2084-46A2-4E4E-B892-B0B396C5588BQ33770940-7E1503DA-8AFB-49C8-B804-154EA6CE4A75Q34092261-C4DD3439-16C7-4EE1-8945-D11E25169B41Q34556705-E554DD54-041E-4B75-AD1E-054CC9517195Q34574464-A4224834-EEAD-4728-8AD9-B281EC19D445Q35540369-EA2DBC23-8429-4D78-ACC2-6CC4AE9CC890Q36388561-3043E9B4-F04B-4565-964E-8AE75895CFDAQ36520625-03BFD4CE-83CF-4318-95A6-6C0BCD2E2177Q36546512-89BC5540-8826-4D5C-A953-53647DB764A0Q36572028-ACC1FECE-24B3-445E-A683-B03375261DB9Q36582769-18A841D0-5420-47A1-B319-67EC5A9FD7A0Q36822295-6639E7CB-2F17-4816-B9C9-4DFEC456BB21Q36959256-21FF454D-924D-4BD4-BB33-215E67E9A0B8Q37139026-C13F74AB-0D5A-4036-85D3-B89F687677EBQ37178955-B5706A1D-1297-4611-9DC9-58EB9D844823Q37436616-BB4B8CBE-52A5-4155-8FCD-049F450F7E2BQ37639747-BFA4AF1D-AEBA-4ADB-A3DF-3CC221C0DA86Q37670716-509156ED-83A0-4AD8-92B8-4ABC3CF53565Q37947688-330AD79F-73A5-4407-A000-3842B6B2F763Q38015346-7ED18029-426E-4E53-91CC-267228414808Q38066159-3AC6FB3C-0398-4663-A667-73A3EF2A9824Q38071004-4F91AA76-A064-473E-B395-E3C616E92FEEQ38162657-C3903BA2-A9A9-466A-B194-97F0EF45E923Q38179262-2714BD28-9B11-4920-8E28-2EC33ED5CC93Q38204719-5AED6D3A-9AE9-4B36-A48E-8F97F82E4624Q38212604-ADEAB473-CDA8-46C1-98F0-0CEC450619D9Q38331105-5D0034D2-B921-46F3-844F-673155DCCFDBQ42677745-CAE717E4-F7C9-4EEB-AE97-438C29B229F6Q47811906-BEB7443A-1D0C-4E30-BB76-6D72EA123F4FQ51896759-0239D169-19CE-44A9-9F54-3E0A1D1C244DQ52317633-F07D7F91-705C-4E66-9760-2866B97AB2C4Q57418133-643ABF75-D606-4A79-94C9-6CE8E293A427
P2860
Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@en
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@nl
type
label
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@en
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@nl
prefLabel
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@en
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@nl
P2093
P2860
P1476
Use of lipid-lowering drugs in ...... y-based epidemiological study.
@en
P2093
Eric G Rodriguez
Gary P Stoehr
Hiroko H Dodge
Maria A Birzescu
Mary Ganguli
P2860
P304
P356
10.1046/J.1532-5415.2002.50515.X
P407
P577
2002-11-01T00:00:00Z